In conclusion, our findings highlighted a critical anti-neoplastic role of miR-143 and miR-145 and also showed that RHOA as an oncogene could be post-transcriptionally repressed by miR-143 and miR-145 in thyroid cancer progression. The gene discussed is RHOA; the disease is thyroid gland carcinoma.